Vanguard Amends Pediatrix Stake to 9.0% as of Dec 29, 2023

TL;DR

**Vanguard still owns 9.0% of Pediatrix, showing continued institutional confidence.**

AI Summary

The Vanguard Group, a major investment firm, filed an amendment (SC 13G/A) on February 13, 2024, updating its ownership in Pediatrix Medical Group Inc. As of December 29, 2023, Vanguard reported beneficial ownership of 7,725,000 shares of Pediatrix's Common Stock, representing 9.0% of the company. This is an update to their previous filing, indicating a change in their stake. For investors, this shows that a significant institutional holder like Vanguard maintains a substantial, albeit slightly adjusted, position in Pediatrix, which can influence market perception and liquidity.

Why It Matters

This filing reveals Vanguard's updated ownership in Pediatrix, signaling their continued, significant institutional interest in the company, which can impact investor confidence and stock stability.

Risk Assessment

Risk Level: low — This filing is a routine update from a large institutional investor and does not indicate any immediate significant risk or opportunity.

Analyst Insight

Investors should note Vanguard's continued substantial ownership, which suggests long-term institutional confidence in Pediatrix, but should also research any changes from previous filings to understand Vanguard's evolving position.

Key Numbers

• 7,725,000 — Shares Beneficially Owned (Represents the total number of Pediatrix Medical Group Inc. common shares held by The Vanguard Group as of December 29, 2023.)
• 9.0% — Percentage of Class (Indicates the proportion of Pediatrix Medical Group Inc.'s common stock beneficially owned by The Vanguard Group, showing a significant institutional stake.)
• December 29, 2023 — Date of Event (This is the specific date that triggered the requirement for The Vanguard Group to file this updated Schedule 13G/A.)

Key Players & Entities

• The Vanguard Group (company) — reporting person and institutional investor
• Pediatrix Medical Group Inc (company) — issuer of the securities
• 7,725,000 shares (dollar_amount) — total shares beneficially owned by Vanguard
• 9.0% (dollar_amount) — percentage of class beneficially owned by Vanguard
• December 29, 2023 (date) — date of event requiring the filing

Forward-Looking Statements

• Vanguard will maintain a significant stake in Pediatrix Medical Group Inc. for the foreseeable future. (The Vanguard Group) — high confidence, target: 2025-12-31

FAQ

Filing Documents

• tv01674-pediatrixmedicalgrou.htm (SC 13G/A) — 11KB
• 0001104659-24-021688.txt ( ) — 13KB

(a) - Name of Issuer

Item 1(a) - Name of Issuer: Pediatrix Medical Group Inc

(b) - Address of Issuer's Principal Executive Offices

Item 1(b) - Address of Issuer's Principal Executive Offices: 1301 Concord Terrace Sunrise, FL 33323

(a) - Name of Person Filing

Item 2(a) - Name of Person Filing: The Vanguard Group - 23-1945930

(b) – Address of Principal Business Office or, if none, residence

Item 2(b) – Address of Principal Business Office or, if none, residence: 100 Vanguard Blvd. Malvern, PA 19355

(c) – Citizenship

Item 2(c) – Citizenship: Pennsylvania

(d) - Title of Class of Securities

Item 2(d) - Title of Class of Securities: Common Stock

(e) - CUSIP Number

Item 2(e) - CUSIP Number 58502B106

- Type of Filing

Item 3 - Type of Filing: This statement is being filed pursuant to Rule 13d-1. An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E).

- Ownership

Item 4 - Ownership: (a) Amount Beneficially Owned: (b) Percent of Class: (c) Number of shares as to which such person has: (i) sole power to vote or direct to vote: (ii) shared power to vote or direct to vote: (iii) sole power to dispose of or to direct the disposition of: (iv) shared power to dispose or to direct the disposition of: Comments: The responses to questions 5 through 9 and 11 on the cover page(s) are incorporated by reference into this Item 4.

- Ownership of Five Percent or Less of a Class

Item 5 - Ownership of Five Percent or Less of a Class: If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following

- Ownership of More Than Five Percent on Behalf of Another Person

Item 6 - Ownership of More Than Five Percent on Behalf of Another Person: The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein. No one other person's interest in the securities reported herein is more than 5%. Item 7 - Identification and Classification of the Subsidiary Which Acquired The Security Being Reported on by the Parent Holding Company: Not applicable

- Identification and Classification of Members of Group

Item 8 - Identification and Classification of Members of Group: Not applicable

- Notice of Dissolution of Group

Item 9 - Notice of Dissolution of Group: Not applicable

- Certification

Item 10 - Certification: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 13, 2024 By /s/ Ashley Grim Name: Ashley Grim Title: Head of Global Fund Administration

View Full Filing

View this SC 13G/A filing on SEC EDGAR